scanX
Home
Biocon

Biocon

363.65
-12.20
(-3.25%)
Market Cap (₹ Cr.)
₹45,083
52 Week High
395.80
Book Value
₹165
52 Week Low
217.50
PE Ratio
28.88
PB Ratio
2.28
PE for Sector
39.11
PB for Sector
4.60
ROE
5.13 %
ROCE
6.11 %
Dividend Yield
0.13 %
EPS
₹13.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
35.25 %
Net Income Growth
101.84 %
Cash Flow Change
59.45 %
ROE
79.59 %
ROCE
84.43 %
EBITDA Margin (Avg.)
6.63 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
597
626
684
551
720
725
643
681
641
600
650
630
679
645
557
507
515
588
590
608
581
557
598
490
537
432
405
510
579
490
1,598
615
2,424
569
588
611
572
553
Expenses
503
462
451
440
527
517
486
495
503
488
532
536
561
373
395
403
420
418
434
424
439
404
472
418
425
359
388
439
491
439
462
518
551
441
457
492
480
466
EBITDA
95
164
233
111
193
209
158
186
138
112
119
93
119
272
162
104
95
171
156
183
142
153
126
72
112
73
17
71
87
51
1,136
97
1,874
128
132
120
91
87
Operating Profit %
10 %
11 %
13 %
10 %
17 %
26 %
21 %
24 %
20 %
15 %
12 %
9 %
14 %
12 %
13 %
9 %
9 %
13 %
17 %
15 %
9 %
22 %
16 %
8 %
14 %
6 %
-6 %
7 %
5 %
1 %
6 %
7 %
-9 %
14 %
12 %
13 %
10 %
9 %
Depreciation
32
34
35
36
36
37
38
38
38
37
33
33
32
22
23
23
23
24
24
25
25
26
26
26
25
26
27
28
28
29
30
29
29
30
31
31
30
31
Interest
0
0
0
0
2
1
2
1
1
1
0
0
-0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
21
48
48
55
56
40
55
Profit Before Tax
62
130
199
75
156
172
118
147
99
74
85
60
87
250
137
79
71
146
132
158
117
127
100
46
86
47
-9
43
59
23
1,106
47
1,796
50
46
33
22
1
Tax
15
28
124
11
38
30
48
43
-97
20
17
16
15
20
18
7
0
34
26
37
15
42
5
13
19
17
-3
18
21
7
119
11
-13
4
8
12
-9
2
Net Profit
48
102
74
64
129
141
70
104
204
55
68
44
72
230
120
73
71
112
106
121
102
85
95
33
68
29
-7
26
38
15
988
35
1,811
47
35
24
14
1
EPS in ₹
2.39
5.18
3.77
3.25
6.56
7.21
3.57
5.30
10.37
0.92
1.16
0.74
1.22
1.95
1.02
0.62
0.60
0.95
0.90
1.02
0.86
0.72
0.80
0.28
0.57
0.24
-0.06
0.21
0.32
0.12
8.28
0.29
15.17
0.39
0.29
0.20
0.12
0.01
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
3,333
7,098
7,469
7,727
8,240
8,311
8,574
8,869
13,030
13,768
Fixed Assets
914
938
938
903
1,101
793
798
870
961
958
Current Assets
1,736
2,371
2,379
2,058
2,511
2,084
2,169
2,402
2,566
2,760
Capital Work in Progress
58
172
241
319
255
152
179
285
344
560
Investments
84
3,809
3,888
4,199
4,093
4,953
5,413
5,280
9,271
9,319
Other Assets
2,277
2,179
2,402
2,307
2,792
2,413
2,184
2,434
2,454
2,932
Total Liabilities
749
1,102
928
988
1,125
774
667
776
2,114
2,856
Current Liabilities
564
863
705
832
993
728
550
591
698
691
Non Current Liabilities
185
239
223
157
132
46
116
185
1,416
2,165
Total Equity
2,584
5,997
6,541
6,739
7,115
7,537
7,907
8,093
10,916
10,912
Reserve & Surplus
2,484
5,897
6,441
6,439
6,815
6,937
7,307
7,493
10,316
10,312
Share Capital
100
100
100
300
300
600
600
600
600
600
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
112
-32
52
-252
217
69
-122
-142
86
-74
Investing Activities
145
-313
104
-553
315
-189
-721
-302
-1,173
-295
Operating Activities
125
208
186
355
110
387
571
48
219
-123
Financing Activities
-158
73
-238
-55
-208
-129
28
112
1,039
344
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
60.67 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
FIIs
16.30 %
15.91 %
15.74 %
16.00 %
15.62 %
16.31 %
15.79 %
14.42 %
10.20 %
9.52 %
7.96 %
6.55 %
5.63 %
5.90 %
DIIs
7.14 %
7.53 %
7.44 %
7.36 %
8.36 %
7.72 %
7.76 %
8.63 %
11.90 %
12.59 %
14.08 %
14.51 %
13.68 %
14.30 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
14.96 %
15.02 %
15.46 %
15.34 %
14.76 %
14.60 %
15.18 %
15.73 %
16.71 %
16.76 %
16.92 %
17.96 %
19.73 %
18.89 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,836.00 4,47,691.91 42.46 49,887.17 12.06 9,648 42.62 61.03
Cipla
1,651.60 1,34,956.56 30.36 26,520.66 14.17 4,155 17.77 60.15
Zydus Life Science
1,079.95 1,11,727.19 26.80 19,831.50 13.82 3,831 30.78 34.07
Dr Reddys Laboratories
6,567.80 1,10,648.92 19.88 28,905.40 12.36 5,578 -0.90 36.38
Lupin
2,224.95 1,03,570.56 45.76 20,141.50 19.94 1,936 77.69 59.35
Mankind Pharma
2,395.60 98,296.04 50.09 10,615.63 19.57 1,942 9.89 53.00
Aurobindo Pharma
1,539.15 90,940.60 25.35 29,559.25 17.55 3,169 61.17 55.58
Alkem Laboratories
6,090.30 74,370.03 34.59 12,978.42 9.84 1,811 91.18 53.74
Glenmark Pharmaceuticals
1,646.05 48,348.71 - 12,653.09 6.58 -1,831 96.52 48.26
Biocon
363.65 45,082.53 28.88 15,621.20 35.25 1,298 478.78 48.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
48.38
ATR(14)
Volatile
13.53
STOCH(9,6)
Neutral
53.83
STOCH RSI(14)
Neutral
24.91
MACD(12,26)
Bearish
-0.63
ADX(14)
Weak Trend
18.04
UO(9)
Bearish
39.00
ROC(12)
Uptrend But Slowing Down
0.07
WillR(14)
Neutral
-79.28
Bearish
4
Neutral
5
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.